Atlas Trials

24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis

Clinical trial NCT04303390 · COMPLETED

Trial details

NCT number
NCT04303390
Sponsor
Saud Al Babtain Cardiac Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Surgical Site Infection
Start date
2018-02-06
Primary completion
2022-05-31
Enrollment
568

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.